Cargando…

Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia

Aspergillus fumigatus causes varied clinical syndromes ranging from colonization to deep infections. The mainstay of therapy of Aspergillus diseases is triazoles but several studies globally highlighted variable prevalence of triazole resistance, which hampers the management of aspergillosis. We stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhary, Anuradha, Sharma, Cheshta, Kathuria, Shallu, Hagen, Ferry, Meis, Jacques F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424976/
https://www.ncbi.nlm.nih.gov/pubmed/26005442
http://dx.doi.org/10.3389/fmicb.2015.00428
_version_ 1782370413599260672
author Chowdhary, Anuradha
Sharma, Cheshta
Kathuria, Shallu
Hagen, Ferry
Meis, Jacques F.
author_facet Chowdhary, Anuradha
Sharma, Cheshta
Kathuria, Shallu
Hagen, Ferry
Meis, Jacques F.
author_sort Chowdhary, Anuradha
collection PubMed
description Aspergillus fumigatus causes varied clinical syndromes ranging from colonization to deep infections. The mainstay of therapy of Aspergillus diseases is triazoles but several studies globally highlighted variable prevalence of triazole resistance, which hampers the management of aspergillosis. We studied the prevalence of resistance in clinical A. fumigatus isolates during 4 years in a referral Chest Hospital in Delhi, India and reviewed the scenario in Asia and the Middle East. Aspergillus species (n = 2117) were screened with selective plates for azole resistance. The isolates included 45.4% A. flavus, followed by 32.4% A. fumigatus, 15.6% Aspergillus species and 6.6% A. terreus. Azole resistance was found in only 12 (1.7%) A. fumigatus isolates. These triazole resistant A. fumigatus (TRAF) isolates were subjected to (a) calmodulin and β tubulin gene sequencing (b) in vitro antifungal susceptibility testing against triazoles using CLSI M38-A2 (c) sequencing of cyp51A gene and real-time PCR assay for detection of mutations and (d) microsatellite typing of the resistant isolates. TRAF harbored TR(34)/L98H mutation in 10 (83.3%) isolates with a pan-azole resistant phenotype. Among the remaining two TRAF isolates, one had G54E and the other had three non-synonymous point mutations. The majority of patients were diagnosed as invasive aspergillosis followed by allergic bronchopulmonary aspergillosis and chronic pulmonary aspergillosis. The Indian TR(34)/L98H isolates had a unique genotype and were distinct from the Chinese, Middle East, and European TR(34)/L98H strains. This resistance mechanism has been linked to the use of fungicide azoles in agricultural practices in Europe as it has been mainly reported from azole naïve patients. Reports published from Asia demonstrate the same environmental resistance mechanism in A. fumigatus isolates from two highly populated countries in Asia, i.e., China and India and also from the neighboring Middle East.
format Online
Article
Text
id pubmed-4424976
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-44249762015-05-22 Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia Chowdhary, Anuradha Sharma, Cheshta Kathuria, Shallu Hagen, Ferry Meis, Jacques F. Front Microbiol Microbiology Aspergillus fumigatus causes varied clinical syndromes ranging from colonization to deep infections. The mainstay of therapy of Aspergillus diseases is triazoles but several studies globally highlighted variable prevalence of triazole resistance, which hampers the management of aspergillosis. We studied the prevalence of resistance in clinical A. fumigatus isolates during 4 years in a referral Chest Hospital in Delhi, India and reviewed the scenario in Asia and the Middle East. Aspergillus species (n = 2117) were screened with selective plates for azole resistance. The isolates included 45.4% A. flavus, followed by 32.4% A. fumigatus, 15.6% Aspergillus species and 6.6% A. terreus. Azole resistance was found in only 12 (1.7%) A. fumigatus isolates. These triazole resistant A. fumigatus (TRAF) isolates were subjected to (a) calmodulin and β tubulin gene sequencing (b) in vitro antifungal susceptibility testing against triazoles using CLSI M38-A2 (c) sequencing of cyp51A gene and real-time PCR assay for detection of mutations and (d) microsatellite typing of the resistant isolates. TRAF harbored TR(34)/L98H mutation in 10 (83.3%) isolates with a pan-azole resistant phenotype. Among the remaining two TRAF isolates, one had G54E and the other had three non-synonymous point mutations. The majority of patients were diagnosed as invasive aspergillosis followed by allergic bronchopulmonary aspergillosis and chronic pulmonary aspergillosis. The Indian TR(34)/L98H isolates had a unique genotype and were distinct from the Chinese, Middle East, and European TR(34)/L98H strains. This resistance mechanism has been linked to the use of fungicide azoles in agricultural practices in Europe as it has been mainly reported from azole naïve patients. Reports published from Asia demonstrate the same environmental resistance mechanism in A. fumigatus isolates from two highly populated countries in Asia, i.e., China and India and also from the neighboring Middle East. Frontiers Media S.A. 2015-05-08 /pmc/articles/PMC4424976/ /pubmed/26005442 http://dx.doi.org/10.3389/fmicb.2015.00428 Text en Copyright © 2015 Chowdhary, Sharma, Kathuria, Hagen and Meis. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Chowdhary, Anuradha
Sharma, Cheshta
Kathuria, Shallu
Hagen, Ferry
Meis, Jacques F.
Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia
title Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia
title_full Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia
title_fullStr Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia
title_full_unstemmed Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia
title_short Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia
title_sort prevalence and mechanism of triazole resistance in aspergillus fumigatus in a referral chest hospital in delhi, india and an update of the situation in asia
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424976/
https://www.ncbi.nlm.nih.gov/pubmed/26005442
http://dx.doi.org/10.3389/fmicb.2015.00428
work_keys_str_mv AT chowdharyanuradha prevalenceandmechanismoftriazoleresistanceinaspergillusfumigatusinareferralchesthospitalindelhiindiaandanupdateofthesituationinasia
AT sharmacheshta prevalenceandmechanismoftriazoleresistanceinaspergillusfumigatusinareferralchesthospitalindelhiindiaandanupdateofthesituationinasia
AT kathuriashallu prevalenceandmechanismoftriazoleresistanceinaspergillusfumigatusinareferralchesthospitalindelhiindiaandanupdateofthesituationinasia
AT hagenferry prevalenceandmechanismoftriazoleresistanceinaspergillusfumigatusinareferralchesthospitalindelhiindiaandanupdateofthesituationinasia
AT meisjacquesf prevalenceandmechanismoftriazoleresistanceinaspergillusfumigatusinareferralchesthospitalindelhiindiaandanupdateofthesituationinasia